Cargando…
Matrine inhibits the development and progression of ovarian cancer by repressing cancer associated phosphorylation signaling pathways
Ovarian cancer remains the most lethal gynecologic malignancy with late detection and acquired chemoresistance. Advanced understanding of the pathophysiology and novel treatment strategies are urgently required. A growing body of proteomic investigations suggest that phosphorylation has a pivotal ro...
Autores principales: | Zhang, Xi, Hou, Guoqing, Liu, Andong, Xu, Hui, Guan, Yang, Wu, Yaosong, Deng, Jie, Cao, Xuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787190/ https://www.ncbi.nlm.nih.gov/pubmed/31601793 http://dx.doi.org/10.1038/s41419-019-2013-3 |
Ejemplares similares
-
Src acts as the target of matrine to inhibit the proliferation of cancer cells by regulating phosphorylation signaling pathways
por: Zhang, Xi, et al.
Publicado: (2021) -
Research Progress of Natural Matrine Compounds and Synthetic Matrine Derivatives
por: Li, Jinlei, et al.
Publicado: (2023) -
Effects of matrine in combination with cisplatin on liver cancer
por: Hu, Gaoyu, et al.
Publicado: (2021) -
Research progress on the pharmacological effects of matrine
por: Sun, Yanan, et al.
Publicado: (2022) -
Research Advances on Matrine
por: Sun, Xiao-Ying, et al.
Publicado: (2022)